Silexion Therapeutics (SLXN) Stock Price, News & Analysis

Company Overview

Silexion Therapeutics LTD, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. The company was founded in 2008 and is headquartered in Jerusalem, Israel.

Key Stats

• Today's Range: $0.81 to $0.94
• 50-Day Range: N/A
• 52-Week Range: $0.81 to $4.65
• Volume: 229,988 shs
• Average Volume: 2.46 million shs
• Market Capitalization: $2.87 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SLXN Stock Analysis - Frequently Asked Questions

How have SLXN shares performed this year?

Silexion Therapeutics' stock was trading at $1.47 on January 1st, 2024. Since then, SLXN shares have decreased by 42.0% and is now trading at $0.8528.
View the best growth stocks for 2024 here.

How were Silexion Therapeutics' earnings last quarter?

Silexion Therapeutics Corp (NASDAQ:SLXN) issued its earnings results on Thursday, August, 29th. The company reported ($5.87) earnings per share for the quarter.

How do I buy shares of Silexion Therapeutics?

Shares of SLXN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Last Earnings: 8/29/2024
• Today: 9/18/2024
• Next Earnings (Estimated): 12/05/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Holding & other investment offices
• Sub-Industry: N/A
• Current Symbol: NASDAQ:SLXN
• CUSIP: N/A
• CIK: 2022416
• Web: silexion.com
• Phone: 972-2-674-3430
• Fax: 212-572-6395
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $260,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -11.33%
• Return on Assets: -32.34%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.01
• Quick Ratio: 0.01

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: $0.05 per share
• Price / Cash Flow: 18.10
• Book Value: ($0.74) per share
• Price / Book: -1.15

Miscellaneous

• Outstanding Shares: 3,360,000
• Free Float: N/A
• Market Cap: $2.87 million
• Optionable: N/A
• Beta: -0.12